Signaling pathways
-
BA2742 AZD5582Summary: AZD5582 is an antagonist. - BA2743 BarbadinSummary: Barbadin is a selective interaction inhibitor with values of 19.1 μM and 15.6 μM for β-arrestin1 and β-arrestin2, respectively.
- BA2744 TVB-3166Summary: TVB-3166 is an orally effective, reversible and selective fatty acid synthase inhibitor with 42 nM and 81 nM for FASN and cellular palmitate synthesis, respectively.
- BA2745 OctreotideSummary: Octreotide (SMS201-995) is a growth inhibitor receptor agonist and synthetic octapeptide growth inhibitor analog.
- BA2746 Deferoxamine5 CitationSummary: Deferoxamine (DeferoxamineB) is an iron chelator (binding Fe(III) and many other metal cations) that is widely used to reduce iron accumulation and deposition in tissues.
-
BA2747 MRT-2359Summary: MRT-2359 is a potent, orally active and selective degrader (>30nM and <300nM) that specifically induces protein translation-dependent apoptosis. - BA2748 DegarelixSummary: Degarelix is a competitive, reversible gonadotropin-releasing hormone receptor antagonist.
- BA2749 CWI1-2Summary: CWI1-2 is an inhibitor.
- BA2750 MS177Summary: MS177 is an effective and fast acting degradant.
-
BA2751 CTBSummary: CTB is an activator of p300 histone acetyltransferase.